Hints and tips:
...Less enthused by recent developments will be Joe Biden’s league of trustbusters — including FTC chair Lina Khan — now that a wrench has been thrown in one of the administration’s biggest efforts to rein...
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...Joaquin Duato, a company veteran and Gorsky’s longtime protégé, takes up the reins....
...Gorsky is starting the break-up before he hands over the reins to his successor Joaquin Duato at the start of next year....
...A year later GSK and Pfizer formed a joint venture from their consumer products divisions, which they plan to spin off next year....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...Despite fierce debate, the US is yet to pass legislation to rein in the increases....
...A significant push to rein in drug prices did not emerge and the group also benefited from the prospect of less regulation, Mr Underhill said....
...transition year”, as the company seeks to move beyond these patent expiries — the last it will face until 2024, he believes — and bring to fruition the new medicines he has overseen since assuming the reins...
...On Monday, the US Treasury said it was taking additional steps to “rein in inversions” — transactions in which multinationals change their tax residence by acquiring a foreign company to cut their tax bills...
...This week, the US Treasury department unveiled aggressive plans to rein in inversions and scored an immediate hit, at least in the eyes of the market....
...Successive attempts to ban or rein in the practice have been blocked by a series of legal cases dating back to the 1970s, where the courts ruled that product advertisements were a form of commercial free...
...Pfizer says the window is still open for US companies to use transatlantic deals to lower their tax rates despite President Barack Obama’s threat to rein in the practice....
...“The whole immuno-oncology area is exploding,” says John LaMattina, former head of research and development for Pfizer....
...The possibility of a Pfizer/AstraZeneca deal still has the politicians talking (the chief executives of both were hauled before the UK parliament this week)....
...The Obama administration said on Tuesday that it was exploring ways it could bypass Congress and use the president’s executive authority to rein in inversion deals....
...These forces have led Mr Jimenez and Sir Andrew Witty, GSK’s chief executive, to make their boldest moves since taking the reins of their respective companies, with an ambitious deal to reshuffle billions...
...US shares in AstraZeneca jumped on Monday after it emerged that Pfizer had made a tentative $100bn takeover approach that would have been the biggest pharmaceuticals deal in industry history if accepted....
...Pfizer reported 2012 margins of 46.6 per cent while Roche posting margins of 41.5 per cent. By comparison, consumer staples companies have average ebitda margins close to 20 per cent....
...To be fair to McCain, he has actually been very principled in his opposition to torture – so perhaps the debate is better phrased as libertarians v neocons; or isolationists v interventionists....
...beyondbrics India v China: a new race in biopharmaceuticals, beyondbrics...
...Pfizer was up 0.4 per cent to $19.63. the only stock in the Dow Jones Industrial Average to record gain....
...Combined with expectations for lower power constraints at the end of the year, the Japanese economy should experience a V-shaped recovery in early 2012, he said....
International Edition